Filter
874
Filtered Results: 874
Text search:
GAVI
Featured
Recommendations
81
New Publications
214
Language
Document type
No document type
383
Studies & Reports
208
Strategic & Response Plan
95
Guidelines
82
Manuals
42
Fact sheets
31
Situation Updates
15
Resource Platforms
9
Training Material
7
Infographics
2
Countries / Regions
Global
94
Colombia
30
Congo, Democratic Republic of
28
Liberia
26
Sierra Leone
23
Africa
21
Kenya
20
Latin America and the Carribbean
14
Uganda
14
Nigeria
13
Burkina Faso
13
Ethiopia
13
Myanmar / Burma
12
Madagascar
12
Nepal
10
Syria
10
Guinea
10
Middle East and North Africa
10
Brazil
10
Ghana
9
East and Southern Africa
9
Zambia
9
Benin
8
Malawi
8
Mozambique
8
Germany
8
West and Central Africa
8
Western and Central Europe
8
Bangladesh
8
India
8
Peru
7
South–East Asia Region
7
South Africa
7
Central African Republic
7
Rwanda
6
Senegal
6
Bolivia
6
South Sudan
6
Cameroon
5
Niger
5
Zimbabwe
5
Tanzania
5
Ukraine
4
Lesotho
4
Togo
4
Asia
4
Eastern Europe
4
Yemen
4
Ecuador
4
Pakistan
4
Cambodia
3
Eastern Europe and Central Asia
3
Argentina
3
Namibia
3
Mali
3
Angola
3
Indonesia
3
Chile
2
Afghanistan
2
Philippines
2
Haiti
2
Guinea-Bissau
2
Venezuela
2
France
2
Sudan
2
Honduras
2
Somalia
2
Eswatini/ Swaziland
2
Guatemala
2
Timor Leste/ East Timor
1
Mexico
1
El Salvador
1
China
1
Congo-Brazzaville
1
Burundi
1
USA
1
Saudi Arabia
1
Paraguay
1
Uruguay
1
Japan
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Papua New Guinea
1
Nicaragua
1
Russia
1
Georgia
1
Chad
1
Botswana
1
Iraq
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
332
Clinical Guidelines
65
Women & Child Health
52
Public Health
37
Key Resources
34
Capacity Building
8
Pharmacy & Technologies
7
Toolboxes
COVID-19
136
Health Financing Toolbox
90
TB
46
Rapid Response
40
Ebola & Marburg
39
AMR
37
Global Health Education
31
HIV
20
Planetary Health
18
Polio
17
Mental Health
15
Cholera
12
Pharmacy
12
Conflict
10
Refugee
8
NTDs
8
NCDs
7
Natural Hazards
6
Disability
6
Caregiver
6
Malaria
3
Zika
1
: Development assistance for health (DAH) is one of the most important means for Japan to promote
diplomacy with developing countries and contribute to the international community. This study, for the first time,
estimated the gross disbursement of Japan’s DAH from 2012 to 2016 and clarified its...
The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents
coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance.
T...
Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in t...
Rebuilding Liberia’s health system is crucial for improving the country’s overall health outcomes. This annual report highlights key achievements, challenges,and lessons learned in implementing programmes of technical cooperation with the Government of Liberia from January to December 2022. T...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ...
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
Globalization and Health201612:63; DOI: 10.1186/s12992-016-0195-3
Gesundheit leistet einen grundlegenden Beitrag für ein erfülltes und zufriedenes Leben. Gesundheit ist ein zentrales Menschenrecht, eines der höchsten Güter aller Menschen und zugleich wesentliche Voraussetzung für soziale, wirtschaftliche und politische Entwicklung und Stabilität. Gesundheit ...
Stronger collaboration, better health: global action plan for healthy lives and well-being for all
recommended
The overall objective of the Global Action Plan is to enhance collaboration among 12 global organizations engaged in health, development and humanitarian responses to accelerate country progress on the health-related SDG targets. The Plan presents a new approach to strengthening collaboration among ...
Vacunación frente a la COVID 19: guía de suministro y logística: orientación provisional, 12 febrero de 2021
recommended
12 February 2021
Rabies remains an under-reported neglected zoonosis with a case-fatality rate of almost 100% in humans and animals. Dog-mediated human rabies causes tens of thousands of human deaths annually despite being 100% preventable. More than 95% of human cases are caused by the bite of a rabies-infected dog...
The COVID-19 pandemic has exacerbated and added yet another layer of vulnerability to an already dire web of vulnerabilities of girls in the African continent, which constitute about 49% of the total child population. Critically, gender equality and girls’ multidimensional vulnerability have been ...
WHO/Europe has launched a new guide, providing support to countries on how to apply behavioural and cultural insights (BCI) for health. It presents a simple step-wise approach, complemented by a rich collection of detailed considerations, tools and exercises. The guide is the first of its kind, spec...
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce and combine with wider initiatives, such as those aimed at s...
The scale of West Africa’s Ebola epidemic has been attributed to the weak health systems of affected countries,
their lack of resources, the mobility of communities and their inexperience in dealing with Ebola. This briefing for African Affairs argues that these explanations lack important contex...
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
